Search

Paul A Liberator

from Lewes, DE
Age ~70
Get Report
Also known as:
Paula Liberator, Paul A Libertador
Related to:
Nicholas J Liberator, 43James H Liberator, 64William L OlsonWilliam S Liberator, 96Sharyn D Liberator, 70Liberator Cole, 52Alyx D Liberator, 34William L OlsonCole D Liberator, 40
Connected to:
Alan D Liberatore, 68Amanda L Liberatore, 41Ana M Liberato, 81Angelo Liberato, 107Ann C Liberator, 47Anne R Liberato, 68Bernard J Liberatore, 86Billye F Liberatore, 78Brent Liberati, 32Carol A Liberato, 78

Paul Liberator Phones & Addresses

  • Lewes, DE
  • Holmdel, NJ
  • Jackson, NJ
  • Tinton Falls, NJ
  • Cincinnati, OH
  • Oceanport, NJ
  • 37 Hillcrest Rd, Holmdel, NJ 07733 (732) 598-4730

Work

Position: Financial Professional

Education

Degree: Graduate or professional degree

Emails

p***[email protected]

Publications

Us Patents

Growth Hormone Secretagogue Receptor Family

View page
US Patent:
6531314, Mar 11, 2003
Filed:
Jun 3, 1998
Appl. No.:
09/077674
Inventors:
Joseph P. Arena - Eagleville PA
Doris F. Cully - Scotch Plains NJ
Scott D. Feighner - Highlands NJ
Andrew D. Howard - Park Ridge NJ
Paul A. Liberator - Holmdel NJ
James M. Schaeffer - Westfield NJ
Leonardus H. T. Van Der Ploeg - Scotch Plains NJ
Assignee:
Merck Co., Inc. - Rahway NJ
International Classification:
C12N 1500
US Classification:
435325, 536 231, 536 235, 530350, 435 691, 4353201
Abstract:
Human, swine and rat growth hormone secretagogue receptors have been isolated, cloned and sequenced. Growth hormone secretagogue receptors are new members of the G-protein family of receptors. The growth hormone secretagogue receptors may be used to screen and identify compounds which bind to the growth hormone secretagogue receptor. Such compounds may be used in the treatment of conditions which occur when there is a shortage of growth hormone, such as observed in growth hormone deficient children, elderly patients with musculoskeletal impairment and recovering from hip fracture and osteoporosis.

Polynucleotide Encoding Eimeria Tenella Cgmp Dependent Protein Kinase

View page
US Patent:
6555358, Apr 29, 2003
Filed:
Mar 8, 2000
Appl. No.:
09/521511
Inventors:
Anne Gurnett - Dobbs Ferry NY
Paul A. Liberator - Holmdel NJ
Robert Donald - South Orange NJ
Dennis Schmatz - Cranford NJ
Georgianna Harris - Tinton Falls NJ
Sandra J. Rattray - Somerset NJ
Assignee:
Merck Co., Inc. - Rahway NJ
International Classification:
C12N 110
US Classification:
4352584, 536 232, 435194, 4353201, 435419, 4352523, 43525411
Abstract:
Protozoal cyclic GMP dependent protein kinases have been isolated and cloned. These enzymes may be used in screening assays to identify potential antiprotozoal agents.

Cyclic Gmp Dependent Protein Kinase As A Chemotherapeutic Target For Antiprotozoal Agents

View page
US Patent:
7125700, Oct 24, 2006
Filed:
Jan 21, 2003
Appl. No.:
10/348155
Inventors:
Anne Gurnett - New York NY, US
Robert Donald - South Orange NJ, US
Georgianna Harris - Tinton Falls NJ, US
Paul A. Liberator - Holmdel NJ, US
Dennis Schmatz - Cranford NJ, US
Sandra J. Rattray - Somerset NJ, US
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C12N 9/12
US Classification:
435194
Abstract:
Protozoal cyclic GMP dependent protein kinases have been isolated and cloned. These enzymes may be used in screening assays to identify potential antiprotozoal agents.

Nucleic Acids Encoding Novel Cyclic Gmp Dependent Protein Kinases From

View page
US Patent:
7390892, Jun 24, 2008
Filed:
Dec 18, 2002
Appl. No.:
10/499554
Inventors:
Paul Liberator - Holmdel NJ, US
Dennis Schmatz - Cranford NJ, US
Anne Gurnett - New York NY, US
Carmen Diaz - New York NY, US
Assignee:
Merial Limited - Duluth GA
International Classification:
C07H 21/02
C07H 21/04
C12N 15/00
C12P 1/00
US Classification:
536 232, 536 231, 536 237, 4353201, 435 41
Abstract:
The present invention relates to novel protozoal cyclic GMP dependent protein kinases and genes encoding same that have been isolated from and. Nucleic acid molecules having sequences that encode such proteins as well as antibodies raised against such proteins are also disclosed. These enzymes may be used in screening assays to identify potential antiprotozoal agents. As well, methods to obtain such nucleic acid molecules, proteins, antibodies and inhibitor are also provided as are therapeutic compositions comprising such nucleic acid molecules, proteins, antibodies and inhibitors as well as their use to protect animals from disease caused by parasites such as and.

Polynucleotides Encoding Coccidian Parasite Casein Kinase I, A Chemotherapeutic Target For Antiprotozoal Agents

View page
US Patent:
7671181, Mar 2, 2010
Filed:
Jan 12, 2005
Appl. No.:
10/586374
Inventors:
Robert G. K. Donald - South Orange NJ, US
Paul Liberator - Holmdel NJ, US
Xiaotian Zhong - Edison NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07H 21/04
C12N 15/63
C12N 1/20
C12P 21/00
US Classification:
536 231, 536 232, 4353201, 4352523, 435 711
Abstract:
Isolated nucleic acid molecules encoding coccidian casein kinase I, CKI, enzymes from the species and are disclosed. The isolation of these coccidian CKI cDNA sequences results in the disclosure of purified forms of and CKI proteins, recombinant vectors and recombinant hosts which express coccidian CKI.

Toxoplasma Gondii Cylclic Gmp Dependent Protein Kinase G As A Chemotherapeutic Target For Antiprotozoal Agents

View page
US Patent:
7718390, May 18, 2010
Filed:
Sep 21, 2006
Appl. No.:
11/525062
Inventors:
Anne Gurnett - New York NY, US
Robert Donald - South Orange NJ, US
Georgianna Harris - Tinton Falls NJ, US
Paul A. Liberator - Holmdel NJ, US
Dennis Schmatz - Cranford NJ, US
Sandra J. Rattray - Somerset NJ, US
Assignee:
Merial Limited - Duluth GA
International Classification:
C12Q 1/48
C12N 9/12
US Classification:
435 15, 435194
Abstract:
Protozoal cyclic GMP dependent protein kinases have been isolated and cloned. These enzymes may be used in screening assays to identify potential antiprotozoal agents.

Growth Hormone Secretagogue Receptor Family

View page
US Patent:
20030166144, Sep 4, 2003
Filed:
Nov 25, 2002
Appl. No.:
10/303204
Inventors:
Joseph Arena - Eagleville PA, US
Doris Cully - Scotch Plains NJ, US
Scott Feighner - Highlands NJ, US
Andrew Howard - Park Ridge NJ, US
Paul Liberator - Holmdel NJ, US
James Schaeffer - Westfield NJ, US
Leonardus Van Der Ploeg - Scotch Plains NJ, US
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C12P021/02
C07K014/72
C07H021/04
C12N005/06
US Classification:
435/069100, 435/320100, 435/353000, 530/350000, 536/023500
Abstract:
Human, swine and rat growth hormone secretagogue receptors have been isolated, cloned and sequenced. Growth hormone secretagogue receptors are new members of the G-protein family of receptors. The growth hormone secretagogue receptors may be used to screen and identify compounds which bind to the growth hormone secretagogue receptor. Such compounds may be used in the treatment of conditions which occur when there is a shortage of growth hormone, such as observed in growth hormone deficient children, elderly patients with musculoskeletal impairment and recovering from hip fracture and osteoporosis.

Eimeria Mitis 16S Or Dna Probes

View page
US Patent:
53590503, Oct 25, 1994
Filed:
May 12, 1992
Appl. No.:
7/879640
Inventors:
Prasanta R. Chakraborty - Scotch Plains NJ
Alex Elbrecht - Watchung NJ
Michael Dashkevicz - Jamesburg NJ
Scott D. Feighner - Scotch Plains NJ
Paul A. Liberator - Jackson NJ
Assignee:
Merck and Co., Inc. - Rahway NJ
International Classification:
C07H 2104
C12Q 168
C12P 1934
US Classification:
536 2432
Abstract:
Unique species-specific Eimeria mitis DNA probes comprising divergent DNA sequences are disclosed. The probes ere complementary to a small subunit ribosomal RNA gene of Eimeria mitis.
Control profile
Paul A Liberator from Lewes, DE, age ~70 Get Report